Portland Retail Druggists Association, Inc. v. Abbott Laboratories

510 F.2d 486
CourtCourt of Appeals for the Ninth Circuit
DecidedJune 23, 1975
Docket73--2342
StatusPublished

This text of 510 F.2d 486 (Portland Retail Druggists Association, Inc. v. Abbott Laboratories) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Portland Retail Druggists Association, Inc. v. Abbott Laboratories, 510 F.2d 486 (9th Cir. 1975).

Opinion

510 F.2d 486

1974-2 Trade Cases 75,437

PORTLAND RETAIL DRUGGISTS ASSOCIATION, INC., an Oregon
nonprofit Corporation, on behalf of its assignors,
Plaintiff-Appellant,
v.
ABBOTT LABORATORIES, an Illinois Corporation, et al.,
Defendants-Appellees.

No. 73--2342.

United States Court of Appeals,
Ninth Circuit.

Dec. 26, 1974.
Rehearing Denied March 11, 1975.
Certiorari Granted June 23, 1975.
See 95 S.Ct. 2655.

Roger Tilbury (argued), Portland, Or., Henry Kane (argued), Beaverton, Or., for plaintiff-appellant.

James H. Clarke (argued), Portland, Or., for defendants-appellees.

Before MERRILL and WALLACE, Circuit Judges, and POWELL,* District Judge.

MERRILL, Circuit Judge:

Plaintiff-appellant commenced this action as the assignee of the antitrust claims of more than sixty retail pharmacies engaged in business in the Greater Portland, Oregon, area. Suit was brought against twelve manufacturers of prescription drugs and sought injunctive relief and damages. Appellant's complaint was stated in five claims, only the second of which is involved in this appeal.1 That claim charges that defendant drug manufacturers have violated the Robinson-Patman Act, 15 U.S.C. § 13 et seq. (1970),2 by selling to certain hospitals3 at prices lower than those charged to the retail pharmacies, appellant's assignors; that the favored hospitals, to some extent at least, then engaged in the resale of the drugs so sold. Defendants-appellees contend that the sales in question are exempt from operation of the Act under 15 U.S.C. § 13c (1970), which reads:

'Nothing in sections 13 to 13b and 21a of this title, shall apply to purchases of their supplies for their own use by schools, colleges, universities, public libraries, churches, hospitals, and charitable institutions not operated for profit.'

After limited discovery and submission of affidavits the district court granted summary judgment in favor of appellees on that claim. The court ruled that each of the fourteen hospitals here involved was 'not operated for profit' and that the drugs had been purchased and used for each hospital's 'own use.' Both of these rulings are assigned as error on this appeal.

We reject appellant's contention that the hospitals did not qualify for exemption (even as to that portion of the purchases which might be 'for their own use'), since none of them were 'hospitals (or) charitable institutions not operated for profit.' It was undisputed that the hospitals derived substantial profits from the sale of drugs and from time to time enjoyed over-all operating surpluses. However, the existence of such profits or surpluses is not in itself enough to foreclose availability of the exemption. In an integrated medical center it is to be expected that one department may provide financial support to another. No enterprise such as these could long remain in existence if each department consistently operated at a loss. Nor could it expect long to continue the fortuity of operating each department or the hospital as a whole precisely at the break-even point. There was no allegation that these hospitals (with the possible exception of Kaiser, see infra), distributed assets to any interested person, and they could not do so under the terms of their charters. The surpluses were expended in the over-all cost of continuing operations or invested for the improvement of facilities.4 Accordingly, the district court did not err in ruling that the thirteen hospitals other than Kaiser were 'not operated for profit' within the exemption. Logan Lanes, Inc. v. Brunswick Corp., 378 F.2d 212, 216 (9th Cir.), cert. denied, 389 U.S. 898, 88 S.Ct. 219, 19 L.Ed.2d 216 (1967).5

We believe the district court erred, however, in granting summary judgment as to sales made to Bess Kaiser Hospital. The effect of this hospital's operation as an element of an organization providing comprehensive health services to members for a predetermined fee, and the possibility that some of its physicians, partners in the Permanente Clinic, receive distributions based on net revenues of the Kaiser Foundation Health Plan (to which revenues from drug sales may contribute), appear to present disputed issues of fact which may be material to the hospital's nonprofit status under the exemption. Moreover, in our judgment the proper legal standard for determining whether Bess Kaiser Hospital is 'not operated for profit' in these circumstances cannot be developed on the limited record before us. Since we remand the cause for further proceedings, this issue can more fully be explored below.

The remaining issue is whether purchases of drugs for resale were purchases by the hospitals 'for their own use' as that phrase is used in § 13c. With disputed issues of fact resolved in favor of appellant for purposes of the motion for summary judgment, it appears that drugs were distributed by the hospitals under the following circumstances:

1. They were dispensed to the hospitals' in-patients in the course of treatment.

2. They were dispensed in the course of treatment to patients at emergency clinics operated by the hospitals.

3. They were provided to departing in-patients as take-home prescriptions.

4. They were provided to persons who had been in-patients as renewals of prescriptions which had first been filled while those persons were in-patients.

5. They were sold for home treatment to out-patients either at hospital pharmacies or at out-patient clinics.

6. They were sold to the hospitals' employees and students for the private use of purchasers.

7. They were sold to hospitals' physicians for their personal or family use or for dispensation in the course of their private practice.

8. They were sold to walk-in customers who were not hospital patients.

The circumstances covered by categories 1 and 2, relating to in-patient and emergency treatment, cover by far the greater part of hospital distribution. There is no dispute that such dispensing of drugs in the course of treatment in the hospital is the hospitals' own use. It is as to distribution under other circumstances that the parties are in dispute, both factually, as to the frequency of occurrence, and legally, as to whether those uses of the drugs can properly be regarded as the hospitals' own use.

Appellees justify the uses thus made by the hospitals as proper hospital functions.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
510 F.2d 486, Counsel Stack Legal Research, https://law.counselstack.com/opinion/portland-retail-druggists-association-inc-v-abbott-laboratories-ca9-1975.